Research project

S Crabb: Alliance with Plexxikon: A phase Ib/IIa trial to combine the CSF1 receptor inhibitor PLX3397 with the new generation AR antagonist enzalutamide in metastatic castration resistant prostate cancer

Staff

Lead researchers

Professor Simon Crabb PhD, BSc, MBBS, MRCP

Professor of Exp'tl Cancer Therapeutics
Research interests
  • Bladder cancer
  • Prostate cancer
  • Predictive biomarkers
Connect with Simon

Other researchers

Professor Gareth Griffiths

Director SCTU & Prof of Clinical Trials
Research interests
  • Gareth Griffiths is Professor of Clinical Trials and directs our Southampton Clinical Trials …
  • His works spans the different phases of clinical trials, from small dose finding and safety s…
  • Phase I-III clinical trials
Connect with Gareth

Research outputs